343 related articles for article (PubMed ID: 33713810)
1. Photocoagulation for retinal vein occlusion.
Hayreh SS
Prog Retin Eye Res; 2021 Nov; 85():100964. PubMed ID: 33713810
[TBL] [Abstract][Full Text] [Related]
2. Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion.
Hayreh SS; Rojas P; Podhajsky P; Montague P; Woolson RF
Ophthalmology; 1983 May; 90(5):488-506. PubMed ID: 6192376
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
Zhang H; Xia Y
Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
[TBL] [Abstract][Full Text] [Related]
4. [Ischemia and laser photocoagulation in retinal vein occlusion].
Rehak M; Storch MW; Hattenbach LO; Feltgen N
Ophthalmologie; 2022 Nov; 119(11):1121-1128. PubMed ID: 36357589
[TBL] [Abstract][Full Text] [Related]
5. Steroids and macular edema from retinal vein occlusion.
Glacet-Bernard A; Coscas G; Zourdani A; Soubrane G; Souied EH
Eur J Ophthalmol; 2011; 21 Suppl 6():S37-44. PubMed ID: 23264327
[TBL] [Abstract][Full Text] [Related]
6. Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion.
Guo S; Ren J; Li Z; Fan X; Qin L; Li J
Acta Ophthalmol; 2019 May; 97(3):273-278. PubMed ID: 30803163
[TBL] [Abstract][Full Text] [Related]
7. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
Scott IU; VanVeldhuisen PC; Oden NL; Ip MS; Blodi BA; Hartnett ME; Cohen G;
Ophthalmology; 2011 Feb; 118(2):345-52. PubMed ID: 20926135
[TBL] [Abstract][Full Text] [Related]
8. Comparison between anti-VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis.
Qian T; Zhao M; Xu X
J Clin Pharm Ther; 2017 Oct; 42(5):519-529. PubMed ID: 28639290
[TBL] [Abstract][Full Text] [Related]
9. Update in the Management of Macular Edema Following Retinal Vein Occlusions.
Thorell MR; Goldhardt R
Curr Ophthalmol Rep; 2016 Mar; 4(1):38-47. PubMed ID: 30345164
[TBL] [Abstract][Full Text] [Related]
10. Management of macular edema secondary to central retinal vein occlusion: an evidence-based.
Aref AA; Scott IU
Adv Ther; 2011 Jan; 28(1):40-50. PubMed ID: 21153510
[TBL] [Abstract][Full Text] [Related]
11. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study.
Hayreh SS; Klugman MR; Podhajsky P; Servais GE; Perkins ES
Graefes Arch Clin Exp Ophthalmol; 1990; 228(4):281-96. PubMed ID: 1698170
[TBL] [Abstract][Full Text] [Related]
12. Prevalent misconceptions about acute retinal vascular occlusive disorders.
Hayreh SS
Prog Retin Eye Res; 2005 Jul; 24(4):493-519. PubMed ID: 15845346
[TBL] [Abstract][Full Text] [Related]
13. SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.
Chan CK; Ip MS; Vanveldhuisen PC; Oden NL; Scott IU; Tolentino MJ; Blodi BA;
Ophthalmology; 2011 Jul; 118(7):1364-72. PubMed ID: 21440942
[TBL] [Abstract][Full Text] [Related]
14. Management of macular edema secondary to branch retinal vein occlusion: an evidence-based update.
Aref AA; Scott IU
Adv Ther; 2011 Jan; 28(1):28-39. PubMed ID: 21153509
[TBL] [Abstract][Full Text] [Related]
15. Long-term real-world outcomes in retinal vein occlusions: How close are we to the trials?
Shah PN; Shanmugam MP; Vora UB; Agrawal S; Sirivella I; Suryakanth S; Jayasingh R
Indian J Ophthalmol; 2022 Dec; 70(12):4370-4375. PubMed ID: 36453347
[TBL] [Abstract][Full Text] [Related]
16. The effect of antivascular endothelial growth factor therapy on the development of neovascular glaucoma after central retinal vein occlusion: a retrospective analysis.
Ryu CL; Elfersy A; Desai U; Hessburg T; Edwards P; Gao H
J Ophthalmol; 2014; 2014():317694. PubMed ID: 24800060
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review.
Glanville J; Patterson J; McCool R; Ferreira A; Gairy K; Pearce I
BMC Ophthalmol; 2014 Jan; 14():7. PubMed ID: 24447389
[TBL] [Abstract][Full Text] [Related]
18. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
[TBL] [Abstract][Full Text] [Related]
19. Retinal vein thrombosis: pathogenesis and management.
Rehak M; Wiedemann P
J Thromb Haemost; 2010 Sep; 8(9):1886-94. PubMed ID: 20492457
[TBL] [Abstract][Full Text] [Related]
20. The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.
Papadia M; Misteli M; Jeannin B; Herbort CP
Int Ophthalmol; 2014 Dec; 34(6):1193-201. PubMed ID: 25245600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
